Escitalopram (escitalopram oxalate) NDC 59746-281

NDC codes

FDA NDC Directory

Product NDC (as listed)59746-281Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59746-0281Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59746-281-01	59746028101	100 TABLET, FILM COATED in 1 BOTTLE (59746-281-01)Marketed from Jan 1, 2024
59746-281-05	59746028105	500 TABLET, FILM COATED in 1 BOTTLE (59746-281-05)Marketed from Jan 1, 2024
59746-281-10	59746028110	1000 TABLET, FILM COATED in 1 BOTTLE (59746-281-10)Marketed from Jan 1, 2024
59746-281-30	59746028130	30 TABLET, FILM COATED in 1 BOTTLE (59746-281-30)Marketed from Jan 1, 2024
59746-281-90	59746028190	90 TABLET, FILM COATED in 1 BOTTLE (59746-281-90)Marketed from Jan 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Escitalopram
Generic name (nonproprietary): escitalopram oxalate
Active ingredients: Escitalopram oxalate — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Jubilant Cadista Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202280
Marketing start: Jan 1, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 59746-281_a76a9a9c-0066-4250-9f8e-d5ba78529ed4SPL ID a76a9a9c-0066-4250-9f8e-d5ba78529ed4SPL set ID 2db02476-325f-ee47-a7e5-b5aed56c364cRxCUI 349332, 351249, 351250UNII 5U85DBW7LOUPC 0359746280109, 0359746279011
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459746028101 followed by a unit qualifier and the quantity

Package 59746-0281-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Escitalopram is indicated for the treatment of: major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older. generalized anxiety disorder (GAD) in adults. Additional pediatric use information is approved for AbbVie Inc.’s LEXAPRO (escitalopram) tablets. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled with that information. Escitalopram tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the: treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older ( 1 ) treatment of generalized anxiety disorder (GAD) in adults ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202280

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202280
Product	Strength	Form · route	Labeler	Product NDC
Escitalopramescitalopram oxalate	Escitalopram oxalate 5 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmaceuticals Inc.	59746-279
Escitalopramescitalopram oxalate	Escitalopram oxalate 10 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmaceuticals Inc.	59746-280